These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 23028581)
1. Increased urine and serum nerve growth factor levels in interstitial cystitis suggest chronic inflammation is involved in the pathogenesis of disease. Liu HT; Kuo HC PLoS One; 2012; 7(9):e44687. PubMed ID: 23028581 [TBL] [Abstract][Full Text] [Related]
2. Urinary nerve growth factor level is increased in patients with interstitial cystitis/bladder pain syndrome and decreased in responders to treatment. Liu HT; Tyagi P; Chancellor MB; Kuo HC BJU Int; 2009 Nov; 104(10):1476-81. PubMed ID: 19522864 [TBL] [Abstract][Full Text] [Related]
4. Increased pro-inflammatory cytokines, C-reactive protein and nerve growth factor expressions in serum of patients with interstitial cystitis/bladder pain syndrome. Jiang YH; Peng CH; Liu HT; Kuo HC PLoS One; 2013; 8(10):e76779. PubMed ID: 24146927 [TBL] [Abstract][Full Text] [Related]
5. Decrease of urinary nerve growth factor but not brain-derived neurotrophic factor in patients with interstitial cystitis/bladder pain syndrome treated with hyaluronic acid. Jiang YH; Liu HT; Kuo HC PLoS One; 2014; 9(3):e91609. PubMed ID: 24614892 [TBL] [Abstract][Full Text] [Related]
6. Urinary nerve growth factor correlates with the severity of urgency and pain. Kim SW; Im YJ; Choi HC; Kang HJ; Kim JY; Kim JH Int Urogynecol J; 2014 Nov; 25(11):1561-7. PubMed ID: 24866276 [TBL] [Abstract][Full Text] [Related]
7. Effect of Water Avoidance Stress on serum and urinary NGF levels in rats: diagnostic and therapeutic implications for BPS/IC patients. Dias B; Serrão P; Cruz F; Charrua A Sci Rep; 2019 Oct; 9(1):14113. PubMed ID: 31575913 [TBL] [Abstract][Full Text] [Related]
8. Elevation of serum c-reactive protein in patients with OAB and IC/BPS implies chronic inflammation in the urinary bladder. Chung SD; Liu HT; Lin H; Kuo HC Neurourol Urodyn; 2011 Mar; 30(3):417-20. PubMed ID: 21284020 [TBL] [Abstract][Full Text] [Related]
9. Elevated Urine Levels of Macrophage Migration Inhibitory Factor in Inflammatory Bladder Conditions: A Potential Biomarker for a Subgroup of Interstitial Cystitis/Bladder Pain Syndrome Patients. Vera PL; Preston DM; Moldwin RM; Erickson DR; Mowlazadeh B; Ma F; Kouzoukas DE; Meyer-Siegler KL; Fall M Urology; 2018 Jun; 116():55-62. PubMed ID: 29580781 [TBL] [Abstract][Full Text] [Related]
10. Potential Urine and Serum Biomarkers in Patients with Bladder Pain Syndrome/Interstitial Cystitis. Wang L; Gao J; Zheng S; Wang Z; Zheng S; Luo Z Arch Esp Urol; 2024 May; 77(4):353-358. PubMed ID: 38840277 [TBL] [Abstract][Full Text] [Related]
11. Urinary nerve growth factor could be a biomarker for interstitial cystitis/painful bladder syndrome: a meta-analysis. Qu HC; Zhang W; Yan S; Liu YL; Wang P PLoS One; 2014; 9(9):e106321. PubMed ID: 25181532 [TBL] [Abstract][Full Text] [Related]
12. [Experimental evaluation of interaction of the nerve growth factor and mast cells in patients with interstitial cystitis/bladder pain syndrome]. Sholan RF Urologiia; 2020 Apr; (2):31-34. PubMed ID: 32351060 [TBL] [Abstract][Full Text] [Related]
13. Increased serum nerve growth factor levels in patients with overactive bladder syndrome refractory to antimuscarinic therapy. Liu HT; Lin H; Kuo HC Neurourol Urodyn; 2011 Nov; 30(8):1525-9. PubMed ID: 21826717 [TBL] [Abstract][Full Text] [Related]
14. Urinary IL-33 and galectin-3 increase in patients with interstitial cystitis/bladder pain syndrome (review). Kochiashvili G; Kochiashvili D Georgian Med News; 2014; (232-233):12-5. PubMed ID: 25214264 [TBL] [Abstract][Full Text] [Related]
15. Increased severity of inflammation correlates with elevated expression of TRPV1 nerve fibers and nerve growth factor on interstitial cystitis/bladder pain syndrome. Liu BL; Yang F; Zhan HL; Feng ZY; Zhang ZG; Li WB; Zhou XF Urol Int; 2014; 92(2):202-8. PubMed ID: 24458144 [TBL] [Abstract][Full Text] [Related]
16. Use of Urinary Biomarkers in Discriminating Interstitial Cystitis/Bladder Pain Syndrome from Male Lower Urinary Tract Dysfunctions. Yu WR; Jiang YH; Jhang JF; Kuo HC Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569430 [TBL] [Abstract][Full Text] [Related]
17. Measurements of C-reactive protein (CRP) and nerve-growth-factor (NGF) concentrations in serum and urine samples of dogs with neurologic disorders. Kordass U; Carlson R; Stein VM; Tipold A BMC Vet Res; 2016 Jan; 12():7. PubMed ID: 26746899 [TBL] [Abstract][Full Text] [Related]
18. Urine cytokines as biomarkers for diagnosing interstitial cystitis/bladder pain syndrome and mapping its clinical characteristics. Jiang YH; Jhang JF; Hsu YH; Ho HC; Wu YH; Kuo HC Am J Physiol Renal Physiol; 2020 Jun; 318(6):F1391-F1399. PubMed ID: 32281420 [TBL] [Abstract][Full Text] [Related]
19. Clinical characterization of interstitial cystitis/bladder pain syndrome in women based on the presence or absence of Hunner lesions and glomerulations. Watanabe D; Akiyama Y; Niimi A; Nomiya A; Yamada Y; Sato Y; Nakamura M; Kawai T; Yamada D; Suzuki M; Igawa Y; Kume H; Homma Y Low Urin Tract Symptoms; 2021 Jan; 13(1):139-143. PubMed ID: 32830459 [TBL] [Abstract][Full Text] [Related]
20. Serum sphingosine-1-phosphate levels in bladder pain syndrome/interstitial cystitis patients: could it help in diagnosis? Asi T; Asci A; Altan M; Gudeloglu A; Ergen A World J Urol; 2020 Oct; 38(10):2577-2581. PubMed ID: 31792578 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]